Copper ions are novel therapeutic agents for uterine leiomyosarcoma
Copper ions are novel therapeutic agents for uterine leiomyosarcoma
复制标题
DOI:
10.1016/j.ajog.2019.07.030
复制
发表时间:
2020-01-01
影响因子:
9.8
通讯作者:
Kimura, Tadashi
中科院分区:
文献类型:
--
作者:
Kakuda, Mamoru;Matsuzaki, Shinya;Kimura, Tadashi
BACKGROUND: Multidrug resistance is a major concern in uterine leiomyosarcoma treatment. Development of effective chemotherapies and management of drug resistance in patients is necessary. The copper efflux transporter adenosine triphosphatase copper transporting beta is a member of the P-type adenosine triphosphatase family and is also known as a strong platinum efflux transporter. Various reports have shown the association between adenosine triphosphatase copper transporting beta and platinum resistance; however, suitable inhibitors or methods for inhibiting platinum efflux via adenosine triphosphatase copper transporting beta are not developed.OBJECTIVE: Our study focused on platinum resistance in uterine leiomyosarcoma. The role of adenosine triphosphatase copper transporting beta in uterine leiomyosarcoma resistance to platinum drugs was investigated both in vitro and in vivo.STUDY DESIGN: Adenosine triphosphatase copper transporting beta expression was investigated by Western blotting and the efficacy of copper sulfate pretreatment and cisplatin administration in adenosine triphosphatase copper transporting betaeexpressing cells was investigated both in vitro and in vivo.RESULTS: Western blot analysis of SK-LMS-1 cells (uterine leiomyosarcoma cell line) revealed strong adenosine triphosphatase copper transporting beta expression. A permanent SK-LMS-ATPase copper transporting betaesuppressed cell line (SK-LMS-7B cells) was generated, and cisplatin exhibited a significant antitumor effect in SK-LMS-7B cells, both in vitro (SK-LMS-1 cells, half-maximal inhibitory concentration, 17.2 mM; SK-LMS-7B cells, half-maximal inhibitory concentration, 4.2 mM, P